Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-15,162
Closed -$196K 1153
2019
Q1
$196K Sell
15,162
-5,000
-25% -$87.5K ﹤0.01% 1083
2018
Q4
$304K Sell
20,162
-1,882
-9% -$48.7K ﹤0.01% 1036
2018
Q3
$867K Sell
22,044
-12,713
-37% -$573K 0.01% 937
2018
Q2
$1.71M Hold
34,757
0.01% 822
2018
Q1
$2.08M Sell
34,757
-3,500
-9% -$233K 0.01% 772
2017
Q4
$3.01M Sell
38,257
-14,210
-27% -$1.15M 0.02% 684
2017
Q3
$4.41M Sell
52,467
-60,142
-53% -$4.26M 0.03% 600
2017
Q2
$7.36M Sell
112,609
-2,401
-2% -$163K 0.04% 457
2017
Q1
$8.36M Sell
115,010
-45,966
-29% -$3.02M 0.05% 429
2016
Q4
$9.43M Buy
+160,976
New +$8.5M 0.06% 385

Other funds holding ADNT

Gabelli Funds's ADNT Position: Q2 2019 in Review

Gabelli Funds sold out of Adient (ADNT) in Q2 2019, closing a stake of 15,162 shares — an estimated $196K sold.

Gabelli Funds first reported a position in ADNT in Q4 2016 and held it in 10 quarters. The position peaked at $9.43M in Q4 2016. 314 funds tracked by Wall St. Rank hold ADNT as of Q2 2019.

  • Gabelli Funds reported no remaining Adient position as of Q2 2019 after selling out during the quarter.
  • Gabelli Funds sold 15,162 Adient shares in Q2 2019, an estimated $196K.
  • Gabelli Funds first reported a position in Adient in Q4 2016 and held it in 10 quarters.
  • Gabelli Funds's Adient position peaked at $9.43M in Q4 2016.
  • 314 funds tracked by Wall St. Rank held Adient as of Q2 2019.

Based on Gabelli Funds's 13F filing for Q2 2019, filed 2 Aug 2019.